Exogenous Induction of Cerebral ß-Amyloidogenesis Is Governed by Agent and Host

The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics

Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864

Naturally secreted oligomers of amyloid β protein potently inhibit hippocampal long-term potentiation in vivo

Walsh, D. M., Klyubin, I., Fadeeva, J. V., Cullen, W. K., Anwyl, R., Wolfe, M. S., Rowan, M. J., & Selkoe, D. J. (2002) · Nature · doi:10.1038/416535a · Cited by 4,291

Diffusible, nonfibrillar ligands derived from Aβ 1–42 are potent central nervous system neurotoxins

Lambert, M. P., Barlow, A. K., Chromy, B. A., Edwards, C., Freed, R., Liosatos, M., Morgan, T. E., Rozovsky, I., Trommer, B., Viola, K. L., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6448 · Cited by 3,506

Immunization with amyloid-β attenuates Alzheimer-disease-like pathology in the PDAPP mouse

Schenk, D., Barbour, R., Dunn, W., Gordon, G., Grajeda, H., Guido, T., Hu, K., Huang, J., Johnson-Wood, K., Khan, K., et al. (1999) · Nature · doi:10.1038/22124 · Cited by 3,160

Pathways towards and Away from Alzheimer’s Disease

Mattson, M. P. (2004) · Nature · doi:10.1038/nature02621 · Cited by 3,052

Natural oligomers of the amyloid-β protein specifically disrupt cognitive function

Cleary, J. P., Walsh, D. M., Hofmeister, J. J., Shankar, G. M., Kuskowski, M. A., Selkoe, D. J., & Ashe, K. H. (2004) · Nature Neuroscience · doi:10.1038/nn1372 · Cited by 1,722

Self-Propagating, Molecular-Level Polymorphism in Alzheimer's ß-Amyloid Fibrils

Petkova, A. T., Leapman, R. D., Guo, Z., Yau, W.-M., Mattson, M. P., & Tycko, R. (2005) · Science · doi:10.1126/science.1105850 · Cited by 1,687

MODELS OF AMYLOID SEEDING IN ALZHEIMER'S DISEASE AND SCRAPIE: Mechanistic Truths and Physiological Consequences of the Time-Dependent Solubility of Amyloid Proteins

Harper, J. D., & Lansbury, P. T. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.385 · Cited by 1,652

Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology

Sturchler-Pierrat, C., Abramowski, D., Duke, M., Wiederhold, K.-H., Mistl, C., Rothacher, S., Ledermann, B., Bürki, K., Frey, P., Paganetti, P. A., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13287 · Cited by 1,507

Prion biology: implications for Alzheimer's disease therapeutics

Condello, C., DeGrado, W. F., & Prusiner, S. B. (2020) · The Lancet Neurology · doi:10.1016/s1474-4422(20)30274-x · Cited by 19

Alzheimer’s Disease—Rationales for Potential Treatment with the Thrombin Inhibitor Dabigatran

Grossmann, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094805 · Cited by 20

Transport of cargo from periphery to brain by circulating monocytes

Cintron, A. F., Dalal, N. V., Dooyema, J. M., Betarbet, R. S., & Walker, L. C. (2015) · Brain Research · doi:10.1016/j.brainres.2015.06.047 · Cited by 19

γ-secretase processing of APLP1 leads to the production of a p3-like peptide that does not aggregate and is not toxic to neurons

Minogue, A. M., Stubbs, A. K., Frigerio, C. S., Boland, B., Fadeeva, J. V., Tang, J., Selkoe, D. J., & Walsh, D. M. (2009) · Brain Research · doi:10.1016/j.brainres.2009.01.008 · Cited by 20

The Structural Basis of Amyloid Strains in Alzheimer’s Disease

Makowski, L. (2019) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.9b01302 · Cited by 19

Scientific Rigor Recommendations for Optimizing the Clinical Applicability of Translational Research

Lapchak, P. A. (2012) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.1000e111 · Cited by 18

Transmission of Cerebral β-Amyloidosis Among Individuals

Hamaguchi, T., Ono, K., & Yamada, M. (2022) · Neurochemical Research · doi:10.1007/s11064-022-03566-4 · Cited by 17

The Convergence of Alzheimer’s Disease Pathogenesis Concepts

Kozin, S. A., & Makarov, A. А. (2019) · Molecular Biology · doi:10.1134/s0026893319060104 · Cited by 17

Aβ and Tau Prions Causing Alzheimer’s Disease

Condello, C., Merz, G. E., Aoyagi, A., DeGrado, W. F., & Prusiner, S. B. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-2655-9_16 · Cited by 18

Vaccines for prion diseases: a realistic goal?

Napper, S., & Schätzl, H. M. (2023) · Cell and Tissue Research · doi:10.1007/s00441-023-03749-7 · Cited by 18

Amyloid‐β in Alzheimer's disease: Structure, toxicity, distribution, treatment, and prospects

Yu, Y., Yu, S., Battaglia, G., & Tian, X. (2024) · Ibrain · doi:10.1002/ibra.12155 · Cited by 19

The air–water interface determines the outcome of seeding during amyloidogenesis

Trigg, B., Lee, C. F., Vaux, D. J., & Jean, L. (2013) · Biochemical Journal · doi:10.1042/bj20130605 · Cited by 18

Binding between Prion Protein and Aβ Oligomers Contributes to the Pathogenesis of Alzheimer’s Disease

Kong, C., Xie, H., Gao, Z., Shao, M., Li, H., Shi, R., Cai, L., Gao, S., Sun, T., & Li, C. (2019) · Virologica Sinica · doi:10.1007/s12250-019-00124-1 · Cited by 18

Alzheimer's disease and related dementias

Hardy, J. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139087711.003 · Cited by 18

Amyotrophic lateral sclerosis and organ donation: Is there risk of disease transmission?

Holmes, B. B., & Diamond, M. I. (2012) · Annals of Neurology · doi:10.1002/ana.23684 · Cited by 18

Key Points Concerning Amyloid Infectivity and Prion-Like Neuronal Invasion

Espargaró, A., Busquets, M. A., Estelrich, J., & Sabaté, R. (2016) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2016.00029 · Cited by 18

The Conspicuous Link between Ear, Brain and Heart–Could Neurotrophin-Treatment of Age-Related Hearing Loss Help Prevent Alzheimer’s Disease and Associated Amyloid Cardiomyopathy?

Shityakov, S., Hayashi, K., Störk, S., Scheper, V., Lenarz, T., & Förster, C. Y. (2021) · Biomolecules · doi:10.3390/biom11060900 · Cited by 18

Prions and Prion-Like Pathogens in Neurodegenerative Disorders

Peggion, C., Sorgato, M. C., & Bertoli, A. (2014) · Pathogens · doi:10.3390/pathogens3010149 · Cited by 17

Neurodegenerative disorders: Dysregulation of a carefully maintained balance?

Swart, C., Haylett, W. L., Kinnear, C. J., Johnson, G., Bardien, S., & Loos, B. (2014) · Experimental Gerontology · doi:10.1016/j.exger.2014.09.003 · Cited by 19

Diversity of Abeta deposits in the aged brain: a window on molecular heterogeneity?

Walker, L. C., Rosen, R. F., & LeVine, H. (2008) · PubMed · Cited by 17

The red-hot debate about transmissible Alzheimer's

Abbott, A. (2016) · Nature · doi:10.1038/531294a · Cited by 18

Emerging links between cell competition and Alzheimer's disease

Coelho, D. S., & Moreno, E. (2019) · Journal of Cell Science · doi:10.1242/jcs.231258 · Cited by 19

Thermally triggered self-assembly of κ-casein amyloid nanofibrils and their nanomechanical properties

Lee, J., Lee, J.-H., Paik, S. R., Yeom, B., & Char, K. (2019) · Polymer · doi:10.1016/j.polymer.2019.121626 · Cited by 17

Evidence for the spread of human-derived mutant huntingtin protein in mice and non-human primates

Gosset, P., Maxan, A., Alpaugh, M., Breger, L. S., Dehay, B., Zhu, T., Zhang, L., Qin, C., Cisbani, G., Fortin, N., et al. (2020) · Neurobiology of Disease · doi:10.1016/j.nbd.2020.104941 · Cited by 17

Spreading of Beta-Amyloid in Organotypic Mouse Brain Slices and Microglial Elimination and Effects on Cholinergic Neurons

Moelgg, K., Jummun, F., & Humpel, C. (2021) · Biomolecules · doi:10.3390/biom11030434 · Cited by 18

Synthetic prions and other human neurodegenerative proteinopathies

Le, N. T. T., Narkiewicz, J., Aulić, S., Salzano, G., Tran, T. H., Scaini, D., Moda, F., Giachin, G., & Legname, G. (2014) · Virus Research · doi:10.1016/j.virusres.2014.10.020 · Cited by 19

Brain virtual histology with X-ray phase-contrast tomography Part II: 3D morphologies of amyloid-β plaques in Alzheimer’s disease models

Chourrout, M., Roux, M., Boisvert, C., Gislard, C., Legland, D., Arganda‐Carreras, I., Olivier, C., Peyrin, F., Boutin, H., Rama, N., et al. (2021) · Biomedical Optics Express · doi:10.1364/boe.438890 · Cited by 17

The use of conformation‐specific ligands and assays to dissect the molecular mechanisms of neurodegenerative diseases

Leliveld, S. R., & Korth, C. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21353 · Cited by 17

Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects

Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21

Biomarker evidence for uncoupling of amyloid build‐up and toxicity in Alzheimer's disease

Zetterberg, H., & Blennow, K. (2012) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2012.07.002 · Cited by 16

Implications of prion adaptation and evolution paradigm for human neurodegenerative diseases

Kabir, M. E., & Safar, J. (2014) · Prion · doi:10.4161/pri.27661 · Cited by 16

Shedding Light on Alzheimer's β‐Amyloid Aggregation with Chemical Tools

Kapurniotu, A. (2012) · ChemBioChem · doi:10.1002/cbic.201100631 · Cited by 16

Induction of amyloid-β deposits from serially transmitted, histologically silent, Aβ seeds issued from human brains

The Brainbank Neuro-CEB Neuropathology Network, Hérard, A., Petit, F., Gary, C., Guillermier, M., Boluda, S., Garin, C. M., Lam, S., & Dhénain, M. (2020) · Acta Neuropathologica Communications · doi:10.1186/s40478-020-01081-7 · Cited by 16

Aged Cattle Brain Displays Alzheimer's Disease-Like Pathology and Promotes Brain Amyloidosis in a Transgenic Animal Model

Moreno‐González, I., Edwards, G. A., Morales, R., Duran-Aniotz, C. A., Escobedo, G., Márquez, M., Pumarola, M. B., & Soto, C. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.815361 · Cited by 15

An Asymmetric Dimer as the Basic Subunit in Alzheimer’s Disease Amyloid β Fibrils

del Amo, J. M. L., Schmidt, M., Fink, U., Dasari, M., Fändrich, M., & Reif, B. (2012) · Angewandte Chemie · doi:10.1002/ange.201200965 · Cited by 16

Review: Cellular repair strategies in Parkinson's disease

Winner, B., Weisenhorn, D. M. V., Lie, D. C., Blümcke, I., & Winkler, J. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285608100324 · Cited by 16

Alternative salt bridge formation in Aβ—a hallmark of early-onset Alzheimer's disease?

Schledorn, M., Meier, B. H., & Böckmann, A. (2015) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2015.00014 · Cited by 16

A Connection between the Mitochondrial Permeability Transition Pore, Autophagy, and Cerebral Amyloidogenesis

Šoškić, V., Klemm, M., Proikas‐Cezanne, T., Schwall, G., Poznanović, S., Stegmann, W., Groebe, K., Zengerling, H., Schoepf, R., Burnet, M. W. M., et al. (2008) · Journal of Proteome Research · doi:10.1021/pr700686x · Cited by 17

Amyloid in skin and brain: What′s the link?

Schreml, S., Kaiser, E., Landthaler, M., Szeimies, R., & Babilas, P. (2010) · Experimental Dermatology · doi:10.1111/j.1600-0625.2010.01166.x · Cited by 16

Transsynaptic Ganglion Cell Degeneration in Adult Patients After Occipital Lobe Stroke

Donaldson, L., Chen, M., & Margolin, E. (2022) · Journal of Neuro-Ophthalmology · doi:10.1097/wno.0000000000001657 · Cited by 15

Synthetic, Cell-Derived, Brain-Derived, and Recombinant β-Amyloid: Modelling Alzheimer’s Disease for Research and Drug Development

Varshavskaya, K. B., Mitkevich, V. A., Makarov, A. А., & Barykin, E. P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315036 · Cited by 17

Transformation of non-neuritic into neuritic plaques during AD progression drives cortical spread of tau pathology via regenerative failure

Tsering, W., Hery, G. P., Phillips, J. L., Lolo, K., Bathe, T., Villareal, J. A. B., Ruan, I. Y., & Prokop, S. (2023) · Acta Neuropathologica Communications · doi:10.1186/s40478-023-01688-6 · Cited by 15

Human haptoglobin phenotypes and concentration determination by nanogold-enhanced electrochemical impedance spectroscopy

Cheng, T.-M., Lee, T.-C., Tseng, S.-H., Chu, H., Pan, J., & Chang, C. (2011) · Nanotechnology · doi:10.1088/0957-4484/22/24/245105 · Cited by 15

Specific aromatic foldamers potently inhibit spontaneous and seeded Aβ42 and Aβ43 fibril assembly

Seither, K. M., McMahon, H. A., Singh, N., Wang, H. H., Cushman-Nick, M., Montalvo, G. L., DeGrado, W. F., & Shorter, J. (2014) · Biochemical Journal · doi:10.1042/bj20131609 · Cited by 15

The struggle by Caenorhabditis elegans to maintain proteostasis during aging and disease

Kikis, E. A. (2016) · Biology Direct · doi:10.1186/s13062-016-0161-2 · Cited by 17

Thiophene‐Based Optical Ligands That Selectively Detect Aβ Pathology in Alzheimer's Disease

Klingstedt, T., Shirani, H., Ghetti, B. F., Vidal, R., & Nilsson, K. P. R. (2021) · ChemBioChem · doi:10.1002/cbic.202100199 · Cited by 14

Copper(II) Coordination to Amyloid β: Murine versus Human Peptide

Eury, H., Bijani, C., Faller, P., & Hureau, C. (2010) · Angewandte Chemie · doi:10.1002/ange.201005838 · Cited by 15

Discrete Pools of Oligomeric Amyloid-β Track with Spatial Learning Deficits in a Mouse Model of Alzheimer Amyloidosis

Chiang, A. C. A., Fowler, S., Reddy, R., Pletniková, O., Troncoso, J. C., Sherman, M. A., Lesné, S., & Jankowsky, J. L. (2017) · American Journal Of Pathology · doi:10.1016/j.ajpath.2017.11.011 · Cited by 17

Entropic Bristles Tune the Seeding Efficiency of Prion-Nucleating Fragments

Michiels, E., Liu, S., Gallardo, R. U., Louros, N. N., Mathelié‐Guinlet, M., Dufrêne, Y. F., Schymkowitz, J. W. H., Vorberg, I. M., & Rousseau, F. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.098 · Cited by 15

Mitochondrial dysfunction induced by a post-translationally modified amyloid linked to a familial mutation in an alternative model of neurodegeneration

Todd, K. L., Fossati, S., Ghiso, J. A., & Rostagno, A. A. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.09.010 · Cited by 15

Atomic-level differences between brain parenchymal- and cerebrovascular-seeded Aβ fibrils

Scherpelz, K. P., Wang, S., Pytel, P., Madhurapantula, R. S., Srivastava, A. K., Sachleben, J. R., Orgel, J., Ishii, Y., & Meredith, S. C. (2021) · Scientific Reports · doi:10.1038/s41598-020-80042-5 · Cited by 12

Cerebral amyloid angiopathy: a narrative review

Noto, N. M., Speth, R. C., & Robison, L. S. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1632252 · Cited by 17

Frontotemporal dementia-like disease progression elicited by seeded aggregation and spread of FUS

Vazquez‐Sanchez, S., Tilkin, B., Gasset-Rosa, F., Zhang, S., Piol, D., McAlonis‐Downes, M., Artates, J. W., Govea-Perez, N., Verresen, Y., Guo, L. E., et al. (2024) · Molecular Neurodegeneration · doi:10.1186/s13024-024-00737-5 · Cited by 17

Cystatin C Triggers Neuronal Degeneration in a Model of Multiple System Atrophy

Suzuki, Y., Jin, C. H., & Yazawa, I. (2014) · American Journal Of Pathology · doi:10.1016/j.ajpath.2013.11.018 · Cited by 15

Cell-free amplification of prions: Where do we stand?

Cazzaniga, F. A., Luca, C. M. G. D., Bistaffa, E., Consonni, A., Legname, G., Giaccone, G., & Moda, F. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.005 · Cited by 14

Trans‐seeding of Alzheimer‐related tau protein by a yeast prion

Flach, M., Leu, C., Martinisi, A., Skachokova, Z. K., Frank, S., Tolnay, M., Stahlberg, H., & Winkler, D. T. (2022) · Alzheimer s & Dementia · doi:10.1002/alz.12581 · Cited by 13

Proteomics for comprehensive characterization of extracellular vesicles in neurodegenerative disease

Vinaiphat, A., & Sze, S. K. (2022) · Experimental Neurology · doi:10.1016/j.expneurol.2022.114149 · Cited by 14

Review: Membrane‐associated misfolded protein propagation in natural transmissible spongiform encephalopathies ( TSEs ), synthetic prion diseases and A lzheimer's disease

Jeffrey, M. (2012) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12004 · Cited by 13

Context dependence of protein misfolding and structural strains in neurodegenerative diseases

Mehta, A. K., Rosen, R. F., Childers, W. S., Gehman, J. D., Walker, L. C., & Lynn, D. G. (2013) · Biopolymers · doi:10.1002/bip.22283 · Cited by 14

Fungal prion proteins studied by solid-state NMR

Lange, A., & Meier, B. H. (2007) · Comptes Rendus Chimie · doi:10.1016/j.crci.2007.08.014 · Cited by 14

Amyloid β derived switch-peptides as a tool for investigation of early events of aggregation: a combined experimental and theoretical approach

Paul, A., Sharma, B., Mondal, T., Thalluri, K., Paul, S., & Mandal, B. (2015) · MedChemComm · doi:10.1039/c5md00466g · Cited by 13

Конвергенция концепций патогенеза болезни Альцгеймера

Kozin, S. A., & Makarov, A. А. (2019) · Molecular Biology · doi:10.1134/s0026898419060107 · Cited by 14

Prion Disease Transmission: Can We Apply Standard Precautions to Prevent or Reduce Risks?

McDonnell, G. E. (2008) · Journal of Perioperative Practice · doi:10.1177/175045890801800706 · Cited by 14

Biology and Genetics of PrP Prion StrainsPreprint

Ghaemmaghami, S. (2016) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026922 · Cited by 14

Neurodegenerative Disease Transmission and Transgenesis in MicePreprint

Dugger, B. N., Perl, D. P., & Carlson, G. A. (2017) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a023549 · Cited by 14

Na,K-ATPase Acts as a Beta-Amyloid Receptor Triggering Src Kinase Activation

Petrushanko, I. Y., Tverskoi, A. M., Barykin, E. P., Petrovskaya, A. V., Strelkova, M. A., Leonova, O. G., Anashkina, A. A., Tolstova, A. P., Adzhubei, A. A., Bogdanova, A. Y., et al. (2022) · Cells · doi:10.3390/cells11172753 · Cited by 13

The unique neuropathological vulnerability of the human brain to aging

Ferrer, I. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101916 · Cited by 15

Neuroanatomical and cognitive biomarkers of alpha‐synuclein propagation in a mouse model of synucleinopathy prior to onset of motor symptoms

Tullo, S., de Miranda, A. S., del Cid‐Pellitero, E., Lim, M. P., Gallino, D., Attaran, A., Patel, R., Novikov, V., Park, M., Beraldo, F. H., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15967 · Cited by 17

Conclusive demonstration of iatrogenic Alzheimer’s disease transmission in a model of stem cell transplantation

Singh, C. S. B., Johns, K. M., Kari, S., Munro, L., Mathews, A., Fenninger, F., Pfeifer, C. G., & Jefferies, W. A. (2024) · Stem Cell Reports · doi:10.1016/j.stemcr.2024.02.012 · Cited by 13

Rapid and sensitive determination of residual prion infectivity from prion-decontaminated surfaces

Simmons, S. M., Payne, V. L., Hrdlicka, J. G., Taylor, J., Larsen, P. A., Wolf, T. M., Schwabenlander, M. D., Yuan, Q., & Bartz, J. C. (2024) · mSphere · doi:10.1128/msphere.00504-24 · Cited by 14

Quantitative detection of grey and white matter amyloid pathology using a combination of K114 and CRANAD-3 fluorescence

Stepanchuk, A. A., Barber, P. A., Lashley, T., Joseph, J. T., & Stys, P. K. (2021) · Neurobiology of Disease · doi:10.1016/j.nbd.2021.105540 · Cited by 13

Seed-induced Aβ deposition alters neuronal function and impairs olfaction in a mouse model of Alzheimer’s disease

Ziegler‐Waldkirch, S., Friesen, M., Loreth, D., Sauer, J., Kemna, S., Hilse, A., Erny, D., Helm, C., d’Errico, P., Prinz, M., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01686-5 · Cited by 13

Prion, prionoids and infectious amyloid

Liberski, P. P. (2013) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(13)70021-x · Cited by 13

Are cheetahs on the run from prion-like amyloidosis?

Caughey, B. W., & Baron, G. S. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0803438105 · Cited by 13

N-domain of angiotensin-converting enzyme hydrolyzes human and rat amyloid-β(1-16) peptides as arginine specific endopeptidase potentially enhancing risk of Alzheimer’s disease

Kugaevskaya, E. V., Veselovsky, A., Indeykina, M., Solovyeva, N. I., Zharkova, M. S., Popov, I., Nikolaev, E., Mantsyzov, A., Makarov, A., & Kozin, S. (2018) · Scientific Reports · doi:10.1038/s41598-017-18567-5 · Cited by 14

Developing Trojan horses to induce, diagnose and suppress Alzheimer’s pathology

Aziz, A. A., & Amtul, Z. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104471 · Cited by 12

Generation, Purification, and Characterization of Cell-invasive DISC1 Protein Species

Bader, V., Ottis, P., Pum, M. E., Huston, J. P., & Korth, C. (2012) · Journal of Visualized Experiments · doi:10.3791/4132 · Cited by 13

Do amyloid oligomers act as traps for misfolded proteins? A hypothesis

Gruschus, J. M. (2008) · Amyloid · doi:10.1080/13506120802193746 · Cited by 13

Molecular Mechanism of Zinc-Dependent Oligomerization of Alzheimer’s Amyloid-β with Taiwan (D7H) Mutation

Kechko, O. I., Adzhubei, A. A., Tolstova, A. P., Indeykina, M. I., Popov, I. A., Zhokhov, S. S., Gnuchev, N. V., Mitkevich, V. A., Makarov, A. А., & Kozin, S. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241411241 · Cited by 12

Cellular Prion Protein and Amyloid-β Oligomers in Alzheimer’s Disease—Are There Connections?

Fułek, M., Hachiya, N., Gachowska, M., Beszłej, J. A., Bartoszewska, E., Kurpas, D., Kurpiński, T., Adamska, H., Poręba, R., Urban, S., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26052097 · Cited by 17

The P’s and Q’s of cellular PrP-Aβ interactions

Westaway, D. A., & Jhamandas, J. H. (2012) · Prion · doi:10.4161/pri.20675 · Cited by 13

The neurodegeneration in Alzheimer disease and the prion protein

Forloni, G., Sclip, A., Borsello, T., & Balducci, C. (2013) · Prion · doi:10.4161/pri.23286 · Cited by 13

Prion diseases: New considerations

Annus, Á., Csáti, A., & Vécsei, L. (2016) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2016.09.006 · Cited by 13

Ensemencement et propagation des lésions dans les maladies neurodégénératives: un nouveau paradigme

Duyckaerts, C. J., Seilhean, D., Sazdovitch, V., Plu, I., Delatour, B., & Potier, M. (2015) · Bulletin de l Académie Nationale de Médecine · doi:10.1016/s0001-4079(19)30883-0 · Cited by 12

Aβ Oligomer Dissociation Is Catalyzed by Fibril Surfaces

Dear, A. J., Thacker, D., Wennmalm, S., Ortigosa-Pascual, L., Andrzejewska, E. A., Meisl, G., Linse, S. S., & Knowles, T. P. J. (2024) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.4c00127 · Cited by 15

Animal models for prion-like diseases

Fernández‐Borges, N., Eraña, H., Venegas, V., Elezgarai, S. R., Harrathi, C., & Castilla, J. (2015) · Virus Research · doi:10.1016/j.virusres.2015.04.014 · Cited by 13

Mechanistic approaches to understand the prion-like propagation of aggregates of the human tau protein

Kumar, H., & Udgaonkar, J. B. (2019) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2019.04.004 · Cited by 12

p53, A Victim of the Prion Fashion

Billant, O., Friocourt, G., Roux, P., & Voisset, C. (2021) · Cancers · doi:10.3390/cancers13020269 · Cited by 12

The Simple Geometry of Transmission and Stabilization in Closed and Open Economies [with Comments]

Giancarlo Corsetti, A., Pesenti, P., Clarida, R. H., & Frankel, J. A. (2007) · NBER International Seminar on Macroeconomics · doi:10.1086/653991 · Cited by 12

The gut-brain axis in the pathogenesis of Parkinson’s disease

Meng, L., Yuan, X., Cao, X., & Zhang, Z. (2019) · Brain Science Advances · doi:10.1177/2096595820902566 · Cited by 12

Intrinsic Stability, Oligomerization, and Amyloidogenicity of HDL-Free Serum Amyloid A

Colón, W., Aguilera, J. J., & Srinivasan, S. (2015) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-17344-3_5 · Cited by 12

Amyloid-β-activated microglia can induce compound proteinopathies

Lee, S. H., Bae, E.-J., Pérez-Acuña, D., Jung, M. K., Han, J. W., Mook‐Jung, I., & Lee, S. (2024) · Brain · doi:10.1093/brain/awae221 · Cited by 11

Transmission of pathogenic protein aggregates in Alzheimer’s disease

Schwarzman, A. L., & Sarantseva, S. V. (2017) · Molecular Biology · doi:10.1134/s0026893317030141 · Cited by 11

Infectious prions do not induce Aβ deposition in an in vivo seeding model

Rasmussen, J., Krasemann, S., Altmeppen, H. C., Schwarz, P., Schelle, J., Aguzzi, A., Glatzel, M., & Jucker, M. (2018) · Acta Neuropathologica · doi:10.1007/s00401-018-1848-5 · Cited by 11

Exogenous Aβ seeds induce Aβ depositions in the blood vessels rather than the brain parenchyma, independently of Aβ strain-specific information

Hamaguchi, T., Kim, J. H., Hasegawa, A., Goto, R., Sakai, K., Ono, K., Itoh, Y., & Yamada, M. (2021) · Acta Neuropathologica Communications · doi:10.1186/s40478-021-01252-0 · Cited by 11

Decontamination of prions

McDonnell, G. E. (2014) · Elsevier eBooks · doi:10.1533/9780857096692.2.346 · Cited by 11

Strain Specificity and Drug Resistance in Anti-Prion Therapy

Miller-Vedam, L. E., & Ghaemmaghami, S. (2013) · Current Topics in Medicinal Chemistry · doi:10.2174/15680266113136660168 · Cited by 11

The Anti-amyloid Compound DO1 Decreases Plaque Pathology and Neuroinflammation-Related Expression Changes in 5xFAD Transgenic Mice.

Boeddrich, A., Babila, J. T., Wiglenda, T., Diez, L., Jacob, M., Nietfeld, W., Huska, M. R., Haenig, C., Groenke, N., Buntru, A., et al. (2019) · Cell Chemical Biology · doi:10.1016/j.chembiol.2018.10.013 · Cited by 8

Contributions of Molecular and Optical Techniques to the Clinical Diagnosis of Alzheimer’s Disease

Bistaffa, E., Tagliavini, F., Matteini, P., & Moda, F. (2020) · Brain Sciences · doi:10.3390/brainsci10110815 · Cited by 11

Self-replicating protein conformations and information transfer: The adaptive β-sheet model

Maury, C. P. J. (2008) · Bioscience hypotheses · doi:10.1016/j.bihy.2008.02.010 · Cited by 11

S5‐03–03: Induction of cerebral beta‐amyloidosis in transgenic mice

Jucker, M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.574

P1‐035: Exogenous induction of Abeta‐amyloidosis: Peripheral and stainless‐steel‐wire inoculations

Eisele, Y. S., Bolmont, T., Heikenwälder, M. F., Yan, Z.-X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., & Jucker, M. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.620

Induction of cerebral beta-amyloidosis: intracerebral versus systemic Abeta inoculation

Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z. X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., et al. (2009) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-26933 · Cited by 4

Induction of cerebral β-amyloidosis: Intracerebral versus systemic Aβ inoculation

Eisele, Y. S., Bolmont, T., Heikenwalder, M., Langer, F., Jacobson, L. H., Yan, Z.-X., Roth, K., Aguzzi, A., Staufenbiel, M., Walker, L. C., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0903200106 · Cited by 279

Exogenous seeding of cerebral β‐amyloid deposition in βAPP‐transgenic rats

Rosen, R. F., Fritz, J. J., Dooyema, J. M., Cintron, A. F., Hamaguchi, T., Lah, J. J., LeVine, H., Jucker, M., & Walker, L. C. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07551.x · Cited by 126